In-vitro Diagnostics Instruments Market GLOBAL INDUSTRY ANALYSIS, TRENDS, MARKET SIZE AND FORECASTS UP TO 2023
In-vitro Diagnostics Instruments Market: Global Industry Analysis, Trends, Market Size and Forecasts up to 2023
Š Infinium Global Research
Page 2
In-vitro Diagnostics Instruments Market: Global Industry Analysis, Trends, Market Size and Forecasts up to 2023
We have produced a new premium report In-vitro Diagnostics Instruments Market. The report covers the analysis of global as well as regional markets of In-vitro Diagnostics Instruments. The objective of the study is to identify market sizes of different segments & countries in recent years and to forecast the values for the next six years. The report also deep dives into the sub-segments of In-vitro Diagnostics Instruments Market by product(immunochemistry, clinical microbiology, POCT, tissue diagnostics, molecular diagnostics, hematology, hemostasis, SMBG), end user(hospitals and diagnostic laboratories, research institutes) through main geographies in the Global Market such as North America, Europe, Asia-Pacific and RoW. The report covers market changing aspects including drivers, restraints, opportunities, and trends expected to encouragement the expansion of the In-vitro Diagnostics Instruments Market during the said period. The report also provides market attractiveness analysis, by geography, and market share analysis, by key players respectively. Some of the prominent participants in the Global In-vitro Diagnostics Instruments Market are Sysmex Corporation, Becton, Dickinson and Company, Ortho-Clinical Diagnostics, Inc., Bio-Rad Laboratories, Inc., Danaher Corporation, Thermo Fisher Scientific, Inc., Qiagen N.V., Johnson & Johnson, Roche Diagnostics, Diasorin S.P.A., BiomÊrieux SA. The global In-vitro diagnostics instruments market was sized over USD 23.79 billion in 2015. The global In-vitro diagnostics instruments market is projected to grow with a CAGR of 9.3% over the forecast period of 2017 to 2023. For More Details Get Free Few Sample Pages of this Premium Report: https://www.infiniumglobalresearch.com/reports/sample-request/807 Adoption of Point-of-Care Testing has Increased Because of Growing Awareness of Personalized Medicine are Likely to Drive the Growth of Market Growing elderly population, rise in occurrence and frequency of chronic diseases and infections, rise in diagnoses population is due to increase in disease like malaria, diabetes, Cancer, tuberculosis, and cardiovascular disease. Adoption of Point-Of-Care testing has increased because of growing awareness of personalized medicine are likely to drive the growth of market. In addition, increasing awareness among the patients, technological innovations and advancement, are expected to positively affect the market growth over the forecast period. Moreover, increasing healthcare costs and lowering compensation affecting instrument sales are the key factors restraining the growth of this market. Increasing investments in emerging economies and increasing implication of friendly diagnosis are likely to bring more opportunities to this market. Segments Covered: The report segments the In-vitro diagnostics instruments market by product and by end user. Market segmentation based on product includes immunochemistry, clinical microbiology, POCT, tissue diagnostics, molecular diagnostics, hematology, hemostasis and Š Infinium Global Research
Page 3
In-vitro Diagnostics Instruments Market: Global Industry Analysis, Trends, Market Size and Forecasts up to 2023
SMBG. Moreover, the global In-vitro diagnostics instruments market based on end user is segmented into hospitals and diagnostic laboratories, homecare and academic and research institutes. Asia-Pacific Region is expected to grow at a Highest CAGR, due to the Growth in Research Activities and Increasing Investments by Leading Players in the Region The report provides regional analysis covering geographies such as Americas, Europe, AsiaPacific and Rest of the World. In this section the key trends and market size for each geography is provided over the period of 2015 – 2023.Americas was the largest market among the geographies due to developed healthcare systems in the U.S. & Canada, and rising acceptance of technologically advanced products in this region. Following the Americas and Europe were also accounted to have a strong hold on global in-vitro diagnostics instruments market. Furthermore, these regions are expected to have a moderate growth rate over the forecast period. Moreover, Asia-Pacific region is expected to grow at a highest CAGR, due to the growth in research activities and increasing investments by leading players in the region. Moreover, Middle East and Africa (covered in ROW region) is expected to grow gradually over the forecast period due to rapid industrialization and changing lifestyle of the consumers in Brazil and other countries. Major Key Players Mentioned in this Premium Report The companies covered in the report include Abbott Laboratories, Inc., Siemens AG, Sysmex Corporation, Becton, Dickinson and Company, Ortho-Clinical Diagnostics, Inc., Bio-Rad Laboratories, Inc., Danaher Corporation, Thermo Fisher Scientific, Inc., Qiagen N.V., Johnson & Johnson, Roche Diagnostics, Diasorin S.P.A., Biomérieux SA. Browse Detailed TOC, Description, and Companies Mentioned in Report @ https://www.infiniumglobalresearch.com/healthcare-medical-devices/global-in-vitrodiagnostics-instruments-market
© Infinium Global Research
Page 4